These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 31899989)

  • 1. How do we choose the appropriate chemotherapeutic agents for biliary tract cancer?
    Neureiter D; Mayr C; Kiesslich T
    Expert Opin Pharmacother; 2020 Feb; 21(3):243-245. PubMed ID: 31899989
    [No Abstract]   [Full Text] [Related]  

  • 2. NRF2: The key to tumor- and patient-dependent chemosensitivity in biliary tract cancer?
    Kiesslich T; Mayr C; Neureiter D
    EBioMedicine; 2019 Nov; 49():9-10. PubMed ID: 31648982
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature.
    Hejna M; Pruckmayer M; Raderer M
    Eur J Cancer; 1998 Jun; 34(7):977-86. PubMed ID: 9849443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary tract cancers: molecular profiling as a tool for treatment decisions. A literature review.
    Berardi R; Scartozzi M; Freddari F; Squadroni M; Santinelli A; Bearzi I; Fabris G; Cascinu S
    Cancer Treat Rev; 2006 Aug; 32(5):333-47. PubMed ID: 16762510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy in biliary tract cancer.
    Tonini G; Frato ME; Vincenzi B; Santini D
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):371-4. PubMed ID: 20496551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new in-vitro drug sensitivity test (collagen-gel droplet embedded-culture drug sensitivity test) in carcinomas of pancreas and biliary tract: possible clinical utility.
    Yasuda H; Takada T; Wada K; Amano H; Isaka T; Yoshida M; Uchida T; Toyota N
    J Hepatobiliary Pancreat Surg; 1998; 5(3):261-8. PubMed ID: 9880773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas.
    Choi CW; Choi IK; Seo JH; Kim BS; Kim JS; Kim CD; Um SH; Kim JS; Kim YH
    Am J Clin Oncol; 2000 Aug; 23(4):425-8. PubMed ID: 10955877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous and intra-arterial chemotherapeutic possibilities in biliopancreatic cancer.
    van Groeningen CJ
    Ann Oncol; 1999; 10 Suppl 4():305-7. PubMed ID: 10436846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASO Author Reflections: Hypoxia-Induced PLOD2 Is a Key Regulator in Epithelial-Mesenchymal Transition and Chemoresistance in Biliary Tract Cancer.
    Okumura Y; Eguchi H
    Ann Surg Oncol; 2018 Nov; 25(12):3738-3739. PubMed ID: 30167909
    [No Abstract]   [Full Text] [Related]  

  • 10. Second-line therapy in advanced biliary tract cancer: what should be the standard?
    Cereda S; Belli C; Rognone A; Mazza E; Reni M
    Crit Rev Oncol Hematol; 2013 Nov; 88(2):368-74. PubMed ID: 23786845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development for combination of surgery and chemotherapy on biliary tract cancer].
    Kato A; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Furukawa K; Yoshitomi H; Mitsuhashi N; Takeuchi D; Takayashiki T; Suda K; Takano S; Miyazaki M
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1685-89. PubMed ID: 18975457
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimum chemotherapy for the management of advanced biliary tract cancer.
    Ghosn M; Kourie HR; El Rassy E; Chebib R; El Karak F; Hanna C; Nasr D
    World J Gastroenterol; 2015 Apr; 21(14):4121-5. PubMed ID: 25892861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-line therapies in advanced biliary tract cancers.
    Tella SH; Kommalapati A; Borad MJ; Mahipal A
    Lancet Oncol; 2020 Jan; 21(1):e29-e41. PubMed ID: 31908303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances for the treatment of pancreatic and biliary tract cancer after first-line treatment failure.
    Onesti CE; Romiti A; Roberto M; Falcone R; Marchetti P
    Expert Rev Anticancer Ther; 2015; 15(10):1183-98. PubMed ID: 26325474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase 2 trial of regorafenib as a single agent in patients with chemotherapy-refractory, advanced, and metastatic biliary tract adenocarcinoma.
    Sun W; Patel A; Normolle D; Patel K; Ohr J; Lee JJ; Bahary N; Chu E; Streeter N; Drummond S
    Cancer; 2019 Mar; 125(6):902-909. PubMed ID: 30561756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer.
    Hong YS; Lee J; Lee SC; Hwang IG; Choi SH; Heo JS; Park JO; Park YS; Lim HY; Kang WK
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):321-8. PubMed ID: 17143602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical outcome of biliary tract cancer with neoadjuvant chemotherapy].
    Kato A; Shimizu H; Yoshidome H; Otsuka M; Furukawa K; Yoshitomi H; Takeuchi D; Takayashiki T; Kuboki S; Suzuki D; Nakajima M; Miyazaki M
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1486-9. PubMed ID: 23133873
    [No Abstract]   [Full Text] [Related]  

  • 18. [Surgical outcome of biliary tract cancer with postoperative chemotherapy].
    Sugawara G; Ebata T; Yokoyama Y; Igami T; Kokuryo T; Tsunoda N; Fukaya M; Uehara K; Itatsu K; Yoshioka Y; Nagino M
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1483-5. PubMed ID: 23130375
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy and histological stratification of biliary tract cancers.
    Cariati A; Piromalli E
    Oncology; 2012; 82(6):352-3. PubMed ID: 22677952
    [No Abstract]   [Full Text] [Related]  

  • 20. Regional combined with systemic chemotherapy in unresectable biliary tract cancers: a phase II study.
    Cantore M; Fiorentini G; Mambrini A; Rabbi C; Zamagni D; Carlone N; Manni A; Caudana R; Torri T
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):59-64. PubMed ID: 16767908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.